How Health IT is Driving Clinical Value in Precision Medicine Cancer Care

What you'll learn

Cancer care is one area of clinical care being transformed by advances in genomic research. In this session, Mark Lewis will share the progress being made at Intermountain Healthcare, a pioneer in both IT innovation and precision medicine. The session will report on how Intermountain is developing an IT platform that provides an architecture to enable the latest advances in research to be shared with clinicians. Among the topics covered are the evolution of the EMR and the creation of a robust data warehouse.

Learning objectives:

• Learn how the IT platform enables precision oncology to be used at the point of care

• Illustrate how the systematic application of precision oncology and capture of patient outcomes demonstrated improved progression-free survival in late-stage cancer patients without increasing cost of care

By signing up, you are confirming you are an adult 18 years or older and you agree to Intel contacting you with marketing-related emails or by telephone with information about Intel products, events, and updates for healthcare professionals. You may unsubscribe at any time. Intel’s web sites and communications are subject to our Privacy Notice and Terms of Use.

Mark Lewis, MD

Gastrointestinal Medical Oncology
Intermountain Healthcare

Bio info: Dr. Mark A. Lewis is the director of gastrointestinal medical oncology at Intermountain Healthcare, a 22-hospital...

Dr. Mark A. Lewis is the director of gastrointestinal medical oncology at Intermountain Healthcare, a 22-hospital system serving Utah and southern Idaho. Previously, he was the chief fellow at Mayo Clinic in Rochester, MN and an assistant professor in general and gastrointestinal medical oncology at the MD Anderson Cancer Center in Houston, Texas. He is also serving as the chair for adolescent & young adult oncology for SWOG cooperative group, a worldwide network of researchers that design and conduct cancer clinical trials.

View more